$CURR Feb. 12, 2020 (GLOBE NEWSWIRE) -- CURE Pharm
Post# of 25331
(Total Views: 176)
Posted On: 02/18/2020 11:59:21 AM
$CURR Feb. 12, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with Vanguard Scientific Systems, Inc., a premier provider of equipment, systems and performance solutions servicing the botanical extraction industry, including both the MIDAS XII, a next-generation GMP compliant supercritical CO2 extraction technology, as well as industrially scaled CO2 facility solutions. The license gives Vanguard the right to practice CURE’s patented cannabis extraction methods, providing customer confidence in choosing Vanguard’s portfolio of extraction manufacturers.
(0)
(0)Scroll down for more posts ▼